Clinical implications of pharmacogenomics of statin treatment

被引:120
|
作者
Mangravite, L. M.
Thorn, C. F.
Krauss, R. M.
机构
[1] Childrens Hosp Oakland, Res Inst, Dept Atherosclerosis Res, Oakland, CA 94609 USA
[2] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA
来源
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 06期
关键词
D O I
10.1038/sj.tpj.6500384
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:360 / 374
页数:15
相关论文
共 50 条
  • [21] Pharmacogenomics of response to statin treatment and susceptibility to statin-induced adverse drug reactions in Asians: a scoping review
    Yow, Hui-Yin
    Hamzah, Sharina
    Suppiah, Vijayaprakash
    Abdul Rahim, Nusaibah
    ASIAN BIOMEDICINE, 2023, 17 (03) : 95 - 114
  • [22] Statin pharmacogenomics in patients with familial hypercholesterolemia
    Apellaniz-Ruiz, Maria
    Urrutia Lafuente, Edurne
    Maillo, Alberto
    Teijido Hermida, Oscar
    Miranda Perez, Maria
    Cobos Hermosa, David
    Gomez-Cabrero, David
    Beloqui Lizaso, Juan Jose
    Ernaga Lorea, Ander
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1184 - 1185
  • [23] Pharmacogenomics and perioperative medicine: implications for modern clinical practice
    Stamer, Ulrike M.
    Stuber, Frank
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2009, 56 (06): : 467 - 468
  • [24] A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
    Mizzi, Clint
    Dalabira, Eleni
    Kumuthini, Judit
    Dzimiri, Nduna
    Balogh, Istvan
    Basak, Nazli
    Bohm, Ruwen
    Borg, Joseph
    Borgiani, Paola
    Bozina, Nada
    Bruckmueller, Henrike
    Burzynska, Beata
    Carracedo, Angel
    Cascorbi, Ingolf
    Deltas, Constantinos
    Dolzan, Vita
    Fenech, Anthony
    Grech, Godfrey
    Kasiulevicius, Vytautas
    Kadasi, L'udevit
    Kucinskas, Vaidutis
    Khusnutdinova, Elza
    Loukas, Yiannis L.
    Macek, Milan, Jr.
    Makukh, Halyna
    Mathijssen, Ron
    Mitropoulos, Konstantinos
    Mitropoulou, Christina
    Novelli, Giuseppe
    Papantoni, Ioanna
    Pavlovic, Sonja
    Saglio, Giuseppe
    Setric, Jadranka
    Stojiljkovic, Maja
    Stubbs, Andrew P.
    Squassina, Alessio
    Torres, Maria
    Turnovec, Marek
    van Schaik, Ron H.
    Voskarides, Konstantinos
    Wakil, Salma M.
    Werk, Anneke
    del Zompo, Maria
    Zukic, Branka
    Katsila, Theodora
    Lee, Ming Ta Michael
    Motsinger-Rief, Alison
    Mc Leod, Howard L.
    van der Spek, Peter J.
    Patrinos, George P.
    PLOS ONE, 2016, 11 (09):
  • [25] When the same treatment has different response: The role of pharmacogenomics in statin therapy
    Zheng, Edward
    Madura, Paulina
    Grandos, Jakub
    Broncel, Marlena
    Pawlos, Agnieszka
    Woz, Ewelina
    Gorzelak-Pabis, Paulina
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [26] Pharmacogenomics in Pancreatic Adenocarcinoma: New Data and Their Clinical Implications
    Strimpakos, Alexios S.
    Syrigos, Kostas N.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (04): : 359 - 362
  • [27] Chances and limitations of pharmacogenomics-implications in clinical studies
    Cascorbi, I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 7 - 7
  • [28] Pharmacogenomics and perioperative medicine - Implications for modern clinical practice
    Kim, Jerry H.
    Schwinn, Debra A.
    Landau, Ruth
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2008, 55 (12): : 799 - 806
  • [29] Pharmacogenomics and perioperative medicine: implications for modern clinical practice
    Ulrike M. Stamer
    Frank Stuber
    Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2009, 56
  • [30] Statin induced diabetes and its clinical implications
    Aiman, Umme
    Najmi, Ahmad
    Khan, Rahat Ali
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2014, 5 (03) : 181 - 185